SPY318.53+7.17 2.30%
DIA270.97+7.64 2.90%
IXIC9,784.55+168.74 1.75%

Nomura Instinet Maintains Buy on Protagonist Therapeutics, Raises Price Target to $33

Nomura Instinet analyst Christopher Marai maintains Protagonist Therapeutics (NASDAQ:PTGX) with a Buy and raises the price target from $29 to $33.

Benzinga · 05/11/2020 12:35

Nomura Instinet analyst Christopher Marai maintains Protagonist Therapeutics (NASDAQ:PTGX) with a Buy and raises the price target from $29 to $33.